Nonmegaloblastic Anemia
Overview
Plain-Language Overview
Nonmegaloblastic anemia is a type of anemia where the red blood cells are smaller or normal in size rather than abnormally large. It affects the blood system by reducing the number of healthy red blood cells, which carry oxygen throughout the body. This condition can cause symptoms like fatigue, weakness, and shortness of breath due to decreased oxygen delivery. Unlike megaloblastic anemia, it does not involve problems with DNA synthesis in the bone marrow. Common causes include chronic diseases, iron deficiency, or blood loss. The main health impact is the body's reduced ability to transport oxygen efficiently, affecting overall energy and organ function.
Clinical Definition
Nonmegaloblastic anemia is defined as anemia characterized by a normal or decreased mean corpuscular volume (MCV) without the presence of megaloblastic changes in the bone marrow. It results from impaired red blood cell production or increased destruction without defective DNA synthesis, distinguishing it from megaloblastic anemia. Common mechanisms include iron deficiency, chronic inflammation, or hemolysis. The bone marrow shows normoblastic erythropoiesis without nuclear-cytoplasmic asynchrony. Clinically, it is significant because it reflects underlying systemic conditions such as chronic disease or nutritional deficiencies that require targeted evaluation. The absence of hypersegmented neutrophils and macro-ovalocytes helps differentiate it from megaloblastic anemia. It is important to identify the cause to guide appropriate management.